A four-drug standardized short regimen for highly resistant TB in South-West Nigeria.
Sign Up to like & getrecommendations! Published in 2023 at "International health"
DOI: 10.1093/inthealth/ihad023
Abstract: BACKGROUND Patients with TB resistant to rifampicin (Rr-TB), and those with additional resistance to fluoroquinolones (pre-XDR-TB), should be treated with bedaquiline-pretomanid-linezolid-moxifloxacin and bedaquiline-pretomanid-linezolid, respectively. However, pretomanid is not yet widely available. METHODS This is a… read more here.
Keywords: drug standardized; bedaquiline; pre xdr; highly resistant ... See more keywords